Friedman SL

References (2)

Title : In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis - Yashaswini_2025_bioRxiv__
Author(s) : Yashaswini CN , Cogliati B , Qin T , To T , Williamson T , Papp TE , Li K , Rasul R , Chen L , Lightstone A , Aghajanian H , Parhiz H , Wang S , Rurik JG , Epstein JA , Friedman SL
Ref : Biorxiv , : , 2025
Abstract :
PubMedSearch : Yashaswini_2025_bioRxiv__
PubMedID: 40060648

Title : FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models - O'Farrell_2022_Sci.Rep_12_15661
Author(s) : O'Farrell M , Duke G , Crowley R , Buckley D , Martins EB , Bhattacharya D , Friedman SL , Kemble G
Ref : Sci Rep , 12 :15661 , 2022
Abstract :
PubMedSearch : O'Farrell_2022_Sci.Rep_12_15661
PubMedID: 36123383